About the Organisers
Fourteen European technology transfer organizations from Austria, Belgium, Czech Republic, France, Germany, Great Britain, Norway and Spain teamed up for BioVaria 2017.
BioVaria was initiated by Ascenion GmbH, an IP asset management company focusing on the life sciences. Ascenion's experienced, interdisciplinary team works together with public research organizations to ensure that promising results of their work are identified, secured and brought to market to the benefit of society. Ascenion was founded in 2001 as a 100% subsidiary of the Life-Science Foundation for the Promotion of Science and Research and has since acquired 23 research institutes in the Helmholtz and Leibniz Associations, as well as the Charité, Hannover Medical School, the MUI - Medical University Innsbruck, the research institute TWINCORE and the UMG - University Medical Center Göttingen as partners. On behalf of these institutes, Ascenion currently markets around 700 technologies and closes an average of about 60 agreements between research and industry per year. The portfolio includes novel therapeutic or diagnostic targets and drug candidates as well as enabling technologies, medical devices and research tools such as vectors and antibodies. Ascenion has also coached numerous spin-offs through their foundation and early growth and currently manages equity in 21 of these companies. Ascenion's headquarters are in Munich, with further offices in Berlin, Brunswick, Hamburg, Hanover and Neuherberg.
Further information at www.ascenion.de